Psychiatric side effects of nonpsychiatric drugs.
D000628:Aminophylline / Q000009:adverse effects; D000700:Analgesics / Q000009:adverse effects; D014151:Anti-Anxiety Agents / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D000932:Antiemetics / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects; D000697:Central Nervous System Stimulants / Q000009:adverse effects; D002707:Chlordiazepoxide / Q000009:adverse effects; D003975:Diazepam / Q000009:adverse effects; D004232:Diuretics / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D005665:Furosemide / Q000009:adverse effects; D006634:Histamine H1 Antagonists / Q000009:adverse effects; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D007328:Insulin / Q000009:adverse effects; D007538:Isoniazid / Q000009:adverse effects; D001523:Mental Disorders / Q000139:chemically induced*; D008750:Methyldopa / Q000009:adverse effects; D010634:Phenobarbital / Q000009:adverse effects; D011241:Prednisone / Q000009:adverse effects
D000700:Analgesics; D014151:Anti-Anxiety Agents; D000900:Anti-Bacterial Agents; D000927:Anticonvulsants; D000932:Antiemetics; D000959:Antihypertensive Agents; D000697:Central Nervous System Stimulants; D004232:Diuretics; D006634:Histamine H1 Antagonists; D006993:Hypnotics and Sedatives; D007328:Insulin; D000628:Aminophylline; D008750:Methyldopa; D002707:Chlordiazepoxide; D005665:Furosemide; D003975:Diazepam; D007538:Isoniazid; D011241:Prednisone; D010634:Phenobarbital